Alerts will be sent to your verified email
Verify EmailMOREPENLAB
Morepen Laboratories
|
Aarti Drugs
|
Solara Active Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
Global DMFs filed
|
211.0 . | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.87 % | 0.79 % | n/a |
Financials
|
|||
5 yr Average ROE
|
13.75 % | 19.9 % | -8.31 % |
5yr average Equity Multiplier
|
1.84 | 2.08 | 1.98 |
5yr Average Asset Turnover Ratio
|
1.34 | 1.13 | 0.55 |
5yr Avg Net Profit Margin
|
5.42 % | 8.4 % | -5.56 % |
Price to Book
|
3.07 | 2.61 | 2.36 |
P/E
|
27.05 | 21.87 | 0.0 |
5yr Avg Cash Conversion Cycle
|
21.38 Days | 82.62 Days | 115.03 Days |
Inventory Days
|
53.55 Days | 66.37 Days | 106.31 Days |
Days Receivable
|
63.5 Days | 113.27 Days | 125.38 Days |
Days Payable
|
98.41 Days | 95.33 Days | 142.19 Days |
5yr Average Interest Coverage Ratio
|
39.33 | 9.51 | 0.55 |
5yr Avg ROCE
|
15.84 % | 22.85 % | 3.01 % |
5yr Avg Operating Profit Margin
|
8.37 % | 14.52 % | 10.34 % |
5 yr average Debt to Equity
|
0.04 | 0.49 | 0.69 |
5yr CAGR Net Profit
|
23.42 % | 3.93 % | n/a |
5yr Average Return on Assets
|
7.36 % | 9.61 % | -2.61 % |
Shareholdings
|
|||
Promoter Holding
|
35.65 % | 55.48 % | 37.94 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 34.64 % |
Change in Promoter Holding (3 Yrs)
|
-2.73 % | -4.35 % | -1.77 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 6.13 % | -2.01 % |
Morepen Laboratories
|
Aarti Drugs
|
Solara Active Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|